Reference · published human trials
The dose that was studied, not the dose you should take.
This is a record of published human trials. Each entry states what one study administered — the amount, the route, the population, the duration — quoted as the paper wrote it, with a link to the paper. That is the entire scope of the page.
Recorded
What a named study gave, to whom, by what route, for how long, and what it reported — with the citation attached so you can check our reading of it against the paper.
Refused
What you should take, how much, how often, in what combination, or toward what outcome. No page here answers that, and no field on this site asks what you are trying to achieve.
On the word “protocol”
It is doing narrower work here than you might expect. On this page a protocol is the procedure a published study ran — its arms, its amounts, its duration. It is not a procedure for you to run. The difference matters enough that we would rather say it plainly than let a nav label imply otherwise: we do not build stacks, we do not calculate doses, and we will not take a goal as an input. Anyone selling you the powder is the last party who should be writing you the schedule, and that includes us.
How an entry gets here
Three rules, and the database enforces the one that matters.
Primary
Entries come from the source records
PubMed, ClinicalTrials.gov, and Europe PMC. Not from a summary of a summary, and not from another vendor's reference page — those are where invented numbers get laundered into fact.
Linked
Every entry carries its link
The source column is not null in the database schema, so an entry with no resolvable link cannot be stored — not merely should not be. If you cannot open the paper from the row, the row does not exist.
Verbatim
The dose is a quotation
Stored and rendered as the paper stated it, for the population that paper studied. It is never normalized, converted to a per-kilogram figure, or restated in our own words, because restating it is how a report becomes an instruction.
Compound record
17 compounds · 0 trials on fileAOD-9604
No trials on fileModified fragment of human growth hormone, residues 176-191. Not somatropin and not a growth hormone.
BPC-157
No trials on filePentadecapeptide derived from a gastric protein. Almost all published work is preclinical.
CJC-1295
No trials on fileGHRH analog, also called modified GRF(1-29). Short half-life relative to the DAC form.
Epitalon
No trials on fileSynthetic tetrapeptide. Human data is limited and largely from a single research group.
GHK-Cu
No trials on fileCopper tripeptide complex. The most studied compound here for topical/cosmetic research.
Hexarelin
No trials on fileSynthetic hexapeptide growth hormone secretagogue.
Ipamorelin
No trials on fileSelective growth hormone secretagogue receptor agonist.
KPV
No trials on fileTripeptide fragment of alpha-MSH.
MOTS-c
No trials on fileMitochondrial-derived peptide.
NAD+
No trials on fileNicotinamide adenine dinucleotide.
PT-141
No trials on fileMelanocortin receptor agonist.
Selank
No trials on fileSynthetic analog of tuftsin.
Semax
No trials on fileACTH(4-10) analog.
Sermorelin
No trials on fileGHRH(1-29) fragment.
TB-500
No trials on fileSynthetic fragment of thymosin beta-4.
Tesamorelin
No trials on fileGHRH analog. The only compound in this catalog with an approved human indication elsewhere.
Thymosin alpha-1
No trials on fileImmunomodulatory peptide with an approved indication in some countries.
Record status · empty
Every row above reads zero, and that is the true count. The record is being built from primary sources one compound at a time, and entries publish as each is checked against the source document rather than in a single batch. A zero here means we have not entered a trial for that compound — and for several of these compounds it will stay at or near zero permanently, because the published human work is thin and the rest is preclinical. That is information about the compound. A page that fills the space anyway has not found trials we missed; it has written something.
Everything in this record reports what published studies did. It is not a recommendation, not medical advice, and not a protocol for use in humans.